Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Healthcare Realty Trust Incorporated Common Stock (HR) vs Merck & Co., Inc. (MRK) Price & Performance

Healthcare Realty Trust Incorporated Common StockTrade
Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Healthcare Realty Trust Incorporated Common Stock vs Merck & Co., Inc. — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.90B), while Merck & Co., Inc. trades at $149.24 (market cap $350.29B). The key difference: Merck & Co., Inc. is far larger — about 59.4× Healthcare Realty Trust Incorporated Common Stock's market cap, and Healthcare Realty Trust Incorporated Common Stock pays the higher dividend (5.57%). Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and Merck & Co., Inc. for 98 Days on average.

HRMRK
Market Cap
$5.90B$350.29B
Volume
4,466,6108,158,912
Sector
Real EstateHealth
52-Week High
$21.87$156.43
52-Week Low
$16.34$82.49
Typical Hold Time
0 Days98 Days
Enterprise Value
$10.29B$397.05B
Dividend Yield
5.57%2.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Healthcare Realty Trust Incorporated Common Stock

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $147.37, up 1.32% today, with a bullish technical signal and strong institutional buying. Recent earnings beats and a $6.7 billion acquisition of Terns Pharmaceuticals highlight growth momentum. Revenue reached $65.01 billion in 2025, with net income at $18.25 billion, though the P/E ratio of 113.58 reflects high valuation expectations.

Outlook is positive with a consensus price target of $158.50, but risks include patent expirations, regulatory scrutiny, and integration challenges from acquisitions. The stock's premium valuation requires sustained earnings growth to justify further upside, with investor sentiment bolstered by analyst support and strategic pipeline expansion.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HR
100% Buy0% Sell
Avg holding period · 0 Days
MRK
57% Buy43% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.

Read more on HR →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Read more on MRK →